Search

Your search keyword '"Lubiński, Jan"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Lubiński, Jan" Remove constraint Author: "Lubiński, Jan" Database OAIster Remove constraint Database: OAIster
134 results on '"Lubiński, Jan"'

Search Results

1. Dissecting the genetic heterogeneity of gastric cancer

2. CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

3. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

4. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

5. Dissecting the genetic heterogeneity of gastric cancer

6. Dissecting the genetic heterogeneity of gastric cancer

7. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study.

8. Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

9. Dissecting the genetic heterogeneity of gastric cancer

10. Dissecting the genetic heterogeneity of gastric cancer

11. Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

12. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

13. Physical activity, sedentary time and breast cancer risk : a Mendelian randomisation study

14. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

15. Incorporating progesterone receptor expression into the PREDICT breast prognostic model.

16. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

17. Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.

18. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.

19. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.

20. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.

21. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

22. Physical activity, sedentary time and breast cancer risk:a Mendelian randomisation study

23. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

24. Physical activity, sedentary time and breast cancer risk:a Mendelian randomisation study

25. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

26. PredictCBC-2.0:a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

27. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

28. PredictCBC-2.0:a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

29. PredictCBC-2.0:a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

30. Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: a Reappraisal

31. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

32. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

33. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

34. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

35. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

36. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

37. Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

38. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

39. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

40. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

41. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

42. Publisher Correction : Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

43. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

44. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

45. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

46. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

47. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

48. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

49. Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

50. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

Catalog

Books, media, physical & digital resources